CDT Equity Inc. (CDT)

CDT Highlights Sarborg's Expanding Quantum Computing IP Portfolio and Application to Drug Discovery

CDT Equity Inc. Announces Reverse Stock Split

CDT Partners with QIMA Life Sciences to Evaluate Novel Tapinarof Combinations in Psoriasis and Vitiligo

CDT Highlights Sarborg's Application of Signature Intelligence and Quantum Computing Models to Mental Health

CDT Provides Capital Update and Confirms No Nasdaq Deficiencies

CDT Appoints Co-Founder James Bligh as Chief Executive Officer to Lead Next Phase of Growth

CDT Validates Enhanced Solid-Form Properties Within Its IP Portfolio

CDT Announces Investment in Pep'd, Expanding into the Fast-Growing US Peptide Market

CDT Increases Stake in Sarborg following its Quantum Computing and Intellectual Property Expansion

CDT Environmental Technology Announces Results of Extraordinary General Meeting

CDT Highlights Sarborg's Patent Filing Extending Quantum-Enabled PRISM Platform to Sugarcane

CDT Equity Inc. Announces Reverse Stock Split

CDT Environmental Technology Investment Holdings Regains Compliance with Nasdaq Minimum Bid Price Requirement

CDT Environmental Technology Investment Holdings Limited to Hold Extraordinary General Meeting on July 28, 2026